Jazz Pharmaceuticals plc Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Jazz Pharmaceuticals plc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Jazz Pharmaceuticals plc Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 60.5M shares, a 3.98% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 60.5M -2.5M -3.98% Oct 31, 2024 10-Q 2024-11-07
Q2 2024 61.8M -1.38M -2.19% Jul 25, 2024 10-Q 2024-08-01
Q1 2024 63M -962K -1.5% Apr 15, 2024 10-K/A 2024-04-26
Q3 2023 63M -9.41K -0.02% Nov 1, 2023 10-Q 2023-11-08
Q2 2023 63.1M +454K +0.72% Aug 2, 2023 10-Q 2023-08-09
Q1 2023 64M +1.69M +2.71% Apr 15, 2023 10-K/A 2023-05-01
Q3 2022 63M +1.5M +2.44% Nov 2, 2022 10-Q 2022-11-09
Q2 2022 62.7M +1.53M +2.51% Jul 27, 2022 10-Q 2022-08-03
Q1 2022 62.3M +5.42M +9.53% Apr 15, 2022 10-K/A 2022-05-02
Q3 2021 61.5M +5.76M +10.3% Nov 2, 2021 10-Q 2021-11-09
Q2 2021 61.1M +5.69M +10.3% Jul 27, 2021 10-Q 2021-08-03
Q1 2021 56.9M +1.54M +2.79% Apr 15, 2021 10-K/A 2021-04-23
Q3 2020 55.7M -859K -1.52% Oct 27, 2020 10-Q 2020-11-02
Q2 2020 55.5M -1.16M -2.05% Jul 28, 2020 10-Q 2020-08-04
Q1 2020 55.3M -1.31M -2.32% Apr 16, 2020 10-K/A 2020-04-24
Q3 2019 56.6M -3.75M -6.22% Oct 31, 2019 10-Q 2019-11-05
Q2 2019 56.6M -3.79M -6.27% Jul 31, 2019 10-Q 2019-08-06
Q1 2019 56.7M -3.34M -5.56% Apr 30, 2019 10-Q 2019-05-07
Q3 2018 60.3M +371K +0.62% Oct 31, 2018 10-Q 2018-11-06
Q2 2018 60.4M +344K +0.57% Jul 31, 2018 10-Q 2018-08-07
Q1 2018 60M -32.6K -0.05% Apr 30, 2018 10-Q 2018-05-08
Q3 2017 60M +58.2K +0.1% Oct 31, 2017 10-Q 2017-11-07
Q2 2017 60.1M -467K -0.77% Jul 31, 2017 10-Q 2017-08-08
Q1 2017 60M -393K -0.65% May 2, 2017 10-Q 2017-05-09
Q3 2016 59.9M -1.61M -2.61% Oct 31, 2016 10-Q 2016-11-08
Q2 2016 60.5M -807K -1.32% Aug 2, 2016 10-Q 2016-08-09
Q1 2016 60.4M -645K -1.06% May 3, 2016 10-Q 2016-05-10
Q3 2015 61.5M +1.01M +1.66% Oct 30, 2015 10-Q 2015-11-09
Q2 2015 61.3M +1.12M +1.86% Jul 31, 2015 10-Q 2015-08-05
Q1 2015 61.1M +1.68M +2.82% May 1, 2015 10-Q 2015-05-07
Q3 2014 60.5M +2.7M +4.68% Oct 28, 2014 10-Q 2014-11-04
Q2 2014 60.2M +2.07M +3.56% Jul 29, 2014 10-Q 2014-08-05
Q1 2014 59.4M +541K +0.92% May 1, 2014 10-Q 2014-05-08
Q3 2013 57.8M -98.5K -0.17% Oct 29, 2013 10-Q 2013-11-05
Q2 2013 58.2M +617K +1.07% Jul 22, 2013 10-Q 2013-08-06
Q1 2013 58.9M +2.12M +3.73% Apr 22, 2013 10-Q 2013-05-07
Q3 2012 57.9M +15.7M +37.3% Nov 2, 2012 10-Q 2012-11-09
Q2 2012 57.5M +15.8M +37.8% Jul 31, 2012 10-Q 2012-08-07
Q1 2012 56.7M Apr 30, 2012 10-Q 2012-05-08
Q3 2011 42.2M Oct 24, 2011 10-Q 2011-11-08
Q2 2011 41.7M Jul 25, 2011 10-Q 2011-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.